Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ICE and apoptosis inhibitors disclosed by SmithKline Beecham

April 15, 1997

Preclinical studies indicate potential of TAK-147 for AD

April 14, 1997

Novel heterocyclic 5-HT1B receptor antagonists disclosed by SKB

April 14, 1997

Antioxidants/sodium channel blockers from Takeda

April 14, 1997

Fournier discloses bradykinin antagonists

April 14, 1997

Astra reveals novel opioid peptides

April 14, 1997

PEP inhibitors from Chinoin

April 14, 1997

Pfizer reports new salt of known NMDA antagonist

April 14, 1997

First launch for new indication of cabergoline

April 11, 1997

Synthelabo prepares serotonergic agents

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...